PROVIDER PROFILE · NPI 1891990156

Mark EliasonM.D.

DermatologySalt Lake City, UTI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,427

Unique beneficiaries

—

Total services

4,030

Distinct HCPCS

Medicare payment

$97K

Peer benchmark

Total Medicare services vs. 149 Dermatology providers in UT — above median (cohort median 2,793).

PRESCRIBING · PART D · 2024

Total Rx claims

649

Beneficiaries

—

Total drug cost

$346K

Distinct drugs

Brand share

22.8%

Top prescribed drugs

Triamcinolone Acetonide102 claims

Mupirocin98 claims

Ketoconazole48 claims

Clobetasol Propionate45 claims

Betamethasone/Propylene Glyc38 claims

QUALITY · MIPS · 2024

Final MIPS score

81.8

Quality

87.0

Cost

52.4

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.29%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$39

Payment records

By payment type

Food and Beverage$39

REFERRAL NETWORK

Where Mark Eliason's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Anneli Bowen Dermatology · Salt Lake City, UT	42	84
David Wada Pathology · Salt Lake City, UT	37	83
NORTHERN UTAH HEALTHCARE CORPORATION	11	18

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history